BGNE

BeiGene, Ltd. (BGNE)

Last Price$226.70.0%
Market Cap$1,846.9M
LTM Operating Income margin
(26.3%)
5Y avg
(194.7%)
Biotechnology industry median
(915.3%)
Stock quality & Intrinsic value
5/10
11.4% undervalued

BeiGene, Ltd. Operating Income margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
BGNE
Healthcare
Crunching data... Almost there!
Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Operating Income margin
(49.0%)
(120.9%)
(643.7%)
(10,940.2%)
(41.3%)
(356.1%)
(224.2%)
(536.7%)
(122.3%)
(126.4%)
(49.1%)
BGNE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BGNE and see if it's the right time to invest.
Dive in

BeiGene, Ltd. (BGNE) Operating Income margin comparison analysis

Crunching data... Almost there!

BGNE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is BeiGene, Ltd.'s Operating Income margin?

As of today, Microsoft Corp's last 12-month Operating Income margin is (26.3%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for BeiGene, Ltd. have been (107.8%) over the past three years, and (204.5%) over the past five years.

2) Is BeiGene, Ltd.'s Operating Income margin Good?

As of today, BeiGene, Ltd.'s Operating Income margin is (26.3%), which is higher than industry median of (915.3%). It indicates that BeiGene, Ltd.'s Operating Income margin is Good.

3) How does BeiGene, Ltd.'s Operating Income margin compare to its peers?

As of today, BeiGene, Ltd.'s Operating Income margin is (26.3%), which is lower than peer median of 14.9%. The list of peers includes SMMT, RPRX, UTHR, NVO, REGN, INCY, VRTX, ALNY, ARGX, BNTX.